• |
Pandawa Logo
Journal of Multidisciplinary Applied Natural Science

##plugins.themes.gdThemes.journalSlogan##

Scopus CiteScore 2025

2.1

Calculated on 05 May, 2025

SJR 2025

0.25

Powered by scimagojr.com

##plugins.themes.gdThemes.language##

Journal of Multidisciplinary Applied Natural Science

##plugins.themes.gdThemes.general.eIssn##: 2774-3047


Articles https://doi.org/10.47352/jmans.2774-3047.471

New Limonoid from Chisocheton macrophyllus: Isolation, Synthesis, Molecular Docking Studies, and Cytotoxicity against Cancer Cells

Muhammad Badrul Huda Nurlelasari Nurlelasari Faris Hermawan Wahyu Safriansyah Unang Supratman Yudha Prawira Budiman

##plugins.themes.gdThemes.author.info##

Muhammad Badrul Huda

https://orcid.org/0009-0003-0464-5543
  • mbadrulhuda@lecturer.undip.ac.id
  • Department of Chemistry, Universitas Padjadjaran, Jatinangor-45363 (Indonesia); Department of Chemistry, Universitas Diponegoro, Semarang-50275 (Indonesia)
  • ##plugins.themes.gdThemes.author.noBiography##

##plugins.themes.gdThemes.author.info##

Nurlelasari Nurlelasari

https://orcid.org/0000-0002-9317-2607
  • nurlelasari@unpad.ac.id
  • Department of Chemistry, Universitas Padjadjaran, Jatinangor-45363 (Indonesia)
  • ##plugins.themes.gdThemes.author.noBiography##

##plugins.themes.gdThemes.author.info##

Faris Hermawan

https://orcid.org/0009-0006-6923-4050
  • fari025@brin.go.id
  • Research Center for Pharmaceutical Ingredients and Traditional Medicine, National Research and Innovation Agency (BRIN), Cibinong-16911 (Indonesia)
  • ##plugins.themes.gdThemes.author.noBiography##

##plugins.themes.gdThemes.author.info##

Wahyu Safriansyah

https://orcid.org/0000-0002-3243-4001
  • wahyu.safriansyah@brin.go.id
  • Eijkman Research Center for Molecular Biology, National Research and Innovation Agency (BRIN), Cibinong-16911 (Indonesia)
  • ##plugins.themes.gdThemes.author.noBiography##

##plugins.themes.gdThemes.author.info##

Unang Supratman

https://orcid.org/0000-0003-1104-2321
  • unang.supratman@unpad.ac.id
  • Department of Chemistry, Universitas Padjadjaran, Jatinangor-45363 (Indonesia); Central Laboratory, Universitas Padjadjaran, Jatinangor-45363 (Indonesia)
  • ##plugins.themes.gdThemes.author.noBiography##

##plugins.themes.gdThemes.author.info##

Yudha Prawira Budiman

https://orcid.org/0000-0002-3929-1891
  • y.p.budiman@unpad.ac.id
  • Department of Chemistry, Universitas Padjadjaran, Jatinangor-45363 (Indonesia)
  • ##plugins.themes.gdThemes.author.noBiography##

##plugins.themes.gdThemes.publishedIn##: Juli 31, 2026

[1]
M. B. Huda, N. Nurlelasari, F. Hermawan, W. Safriansyah, U. Supratman, dan Y. P. Budiman, “New Limonoid from Chisocheton macrophyllus: Isolation, Synthesis, Molecular Docking Studies, and Cytotoxicity against Cancer Cells”, J. Multidiscip. Appl. Nat. Sci., Jul 2026.

##plugins.themes.gdThemes.formatCitations##

Abstrak

Dysobinin is a naturally occurring limonoid and a type of triterpenoid, which shows certain efficacy, although its prospects in the field of pharmacology are still limited. Therefore, this study aimed to improve the pharmacological properties of dysobinin through structural rearrangement. A 56% yield was obtained using Selectfluor to convert dysobinin into a novel molecule, specifically 22α-carboxyacid-dysobinin (5). Compared to the other compounds, 22α-carboxyacid-dysobinin (5) exhibited significantly higher cytotoxicity against human epithelial tumor (HeLa) and B16-F10 cancer cells. However, this compound exhibited the lowest cytotoxicity against MCF-7 cancer cells. Subsequently, a docking study showed that compound 5 had binding energies of -9.61, -7.81, and -6.08 kcal/mol for EGFR, Bcl-2, and Tyrosinase, respectively. In the prediction of pharmacokinetic parameters, compound 5 fulfilled the minimum standard parameters for the ADMET properties. Therefore, compound 5 may be considered a promising lead compound for anticancer development, warranting further optimization and validation.

Referensi

##plugins.themes.gdThemes.article.info##

##plugins.themes.gdThemes.identifiers##

##plugins.generic.funding.fundingData##